Skip to content

The CONVINCE Study followed over 1300 patients for more than two years across eight European countries.

Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations

Latest News

Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations
Dr. Benjamin Hippen on the Improving Organ Transplant Access Rule >

Blog

Dr. Benjamin Hippen on the Improving Organ Transplant Access Rule
Growing Stronger Together: Embracing Diversity >

Together

Growing Stronger Together: Embracing Diversity

For Investors

The Conference Call on Q2 2024 financial results takes place on July 30, 2024

Blog

The Organ Trail: Living Kidney Donors Mark and Lynn Scotch Share Their Story

Personal Stories

Dialysis Nurse Becomes Kidney Patient After COVID-19

Healthcare Professionals

Products, therapies and services for Healthcare Professionals

Learn more

Patients & Families

Patients & Families

Learn more

WHO WE ARE

Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 4.1 million patients worldwide regularly undergo dialysis treatment.

Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the Renal Care Continuum, the company focuses on expanding in complementary areas and in the field of critical care.

~ 52 M

TREATMENTS

> 332,000

PATIENTS SERVED

~ 4,000

CLINICS

~ 40

PRODUCTION SITES

~ 120,000

EMPLOYEES